BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/11/2024 2:23:40 AM | Browse: 408 | Download: 1342
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 91025
Country China
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Medical Informatics
Manuscript Type Observational Study
Article Title Establishment of a cholangiocarcinoma risk evaluation model based on mucin expression levels
Manuscript Source Unsolicited Manuscript
All Author List Chun-Yuan Yang, Li-Mei Guo, Yang Li, Guang-Xi Wang, Xiao-Wei Tang, Qiu-Lu Zhang, Ling-Fu Zhang and Jian-Yuan Luo
ORCID
Author(s) ORCID Number
Li-Mei Guo http://orcid.org/0000-0002-4472-2705
Funding Agency and Grant Number
Corresponding Author Li-Mei Guo, MD, Doctor, Doctor, Professor, Department of Pathology, Institute of Systems Biomedicine, School of Basic Medical Sciences Peking University, Peking University Third Hospital, Peking University Health Science Center, No. 38 Xueyuan Road, Haidian District, Beijing 100191, China. guolimei@bjmu.edu.cn
Key Words Mucin; Cholangiocarcinoma; Single-cell RNA sequencing; Spatial transcriptomics; Prognosis
Core Tip In this study, we have conducted a comprehensive investigation of mucins in cholangiocarcinoma (CCA) using a combination of bioinformatics analysis, including single-cell RNA sequencing and spatial transcriptomics, along with experimental validations. Our findings highlight the significant roles of MUC1, MUC4, and MUC5B in CCA metabolism, contributing to tumor progression and therapy resistance. Additionally, MUC5AC has been identified as a regulator of CCA invasiveness through the WNT signaling. MUC13 and MUC16 are found to play critical roles in tumor-immune interactions, regulating antitumoral immune defense. The collect impact of these mucins enables the development of a CCA prognosis evaluation model that effectively predicts tumor malignancy, treatment effectiveness, and prognosis in CCA cases.
Publish Date 2024-04-11 02:23
Citation Yang CY, Guo LM, Li Y, Wang GX, Tang XW, Zhang QL, Zhang LF, Luo JY. Establishment of a cholangiocarcinoma risk evaluation model based on mucin expression levels. World J Gastrointest Oncol 2024; 16(4): 1344-1360
URL https://www.wjgnet.com/1948-5204/full/v16/i4/1344.htm
DOI https://dx.doi.org/10.4251/wjgo.v16.i4.1344
Full Article (PDF) WJGO-16-1344-with-cover.pdf